0001437749-15-000927.txt : 20150121 0001437749-15-000927.hdr.sgml : 20150121 20150121164607 ACCESSION NUMBER: 0001437749-15-000927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150116 FILED AS OF DATE: 20150121 DATE AS OF CHANGE: 20150121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wrighton-Smith Peter CENTRAL INDEX KEY: 0001592286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 15539025 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2015-01-16 0001586049 Oxford Immunotec Global PLC OXFD 0001592286 Wrighton-Smith Peter C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 1 Chief Executive Officer Share Option (Right to Buy) 14.57 2015-01-16 4 A 0 51403 0 A 2025-01-16 Ordinary Shares 51403 51403 D Option granted under Issuer's 2013 Share Incentive Plan. Options will become exercisable ratably on the first day of each month from February 1, 2015 through January 1, 2019. /s/ Elizabeth M. Keiley, as Attorney-in-Fact 2015-01-21